StockNews.com Begins Coverage on ObsEva (NASDAQ:OBSV)

StockNews.com started coverage on shares of ObsEva (NASDAQ:OBSV) in a research report released on Sunday morning. The brokerage issued a hold rating on the stock.

ObsEva Price Performance

NASDAQ OBSV opened at $0.00 on Friday. ObsEva has a 1 year low of $0.08 and a 1 year high of $2.14. The stock has a market capitalization of $311,884.00, a PE ratio of 0.00 and a beta of 0.68. The business’s 50-day moving average is $0.02 and its 200 day moving average is $0.04.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.